Abstract
Background
Probiotics are pharmaceutical products that contain living bacteria and are used to manage certain disorders, as well as to enhance general health. There are some reports criticizing the quality of these products, highlighting findings such as pathogen contamination and misleading labeling. Regulation and control of probiotics vary between international regulatory authorities, creating a gap between probiotic manufacturers and regulatory bodies.
Methods
In this article, the probiotics available in Saudi Arabia were analyzed in regard to their presented method of identification and labeling information.
Results
Only 1 of 22 products had confirmed the bacterial strain using a genotypic method; the rest presented various phenotypic methods. More than half of the reviewed products did not contain the strain designation on the outside labeling of the probiotic.
Conclusion
The Saudi Food and Drug Authority should act by adopting a new guideline to control and regulate probiotics in Saudi Arabia, which could then be expanded to cover gulf countries (GCC).
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aldawsari, F.S., Bin Helel, B.S., Al shehry, Y.M. et al. Probiotics and Their Quality-Related Concerns: Highlights From the Saudi Arabian Market. Ther Innov Regul Sci 54, 365–369 (2020). https://doi.org/10.1007/s43441-019-00064-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43441-019-00064-8